GMO labeling opponents spent over $27 million in six months

YesNo x

Opponents of mandatory labeling for foods made with genetically modified organisms spent more than $27 million in the first six months of this year on GMO-related lobbying, roughly three times their spending in all of 2013, according to an analysis released Wednesday.

The Grocery Manufacturers Association (GMA) and major food makers such as Coca-Cola Co and PepsiCo Inc and top biotech seed makers Monsanto Co and DuPont were among heavy spenders on GMO labeling-related lobbying, according to a report issued by the Environmental Working Group. The group analyzed lobbying disclosure forms that cited labeling of foods containing genetically modified organisms (GMOs) along with other policy issues.

Coca-Cola spent $4.8 million through the second quarter of this year; PepsiCo spent $2.34 million; DuPont spent $2.4 million, while Monsanto spent $1.08 million, according to the report. All told, the opponents of GMO labeling disclosed $15.2 million in lobbying expenditures for the second quarter of 2014, bringing the six-month total for 2014 to $27.5 million. That compared with $9.3 million disclosed on lobbying the issue by food and biotechnology companies in 2013, according to EWG, a Washington-based nonprofit that supports GMO labeling.

Read the full, original article: U.S. GMO labeling foes triple spending in first half of this year over 2013

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-04-22-at-12.21.32-PM
Viewpoint: Why the retracted Monsanto glyphosate study doesn’t change the science—the world’s most popular herbicide is safe 
Picture1
The FDA couldn’t find a vaccine safety crisis, so it buried its own research
ChatGPT-Image-May-1-2026-11_42_59-AM-2
Viewpoint: NAD is the wellness grifters latest evidence-lite longevity fad. At least the mice are impressed.
ChatGPT-Image-Apr-16-2026-02_56_53-PM
Financial incentives, over diagnosis, and weak oversight: Autism claims are driving up Medicare costs
global warming
‘Implausible’: Top climate scientists reject worst-case scenario—soaring temperatures and fast-rising sea levels
ChatGPT-Image-May-12-2026-11_27_01-AM-2
AI likely to improve health care, research shows—but not for blacks and ethnic minorities
ChatGPT-Image-May-7-2026-01_23_27-PM-2
Viewpoint: Will AI democratize personalized cancer treatment or fuel medical misinformation?

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.